FRZB and type 2 diabetes mellitus: sFRP3 levels in serum and skeletal muscles are significantly reduced in T2DM patients and positively correlated with insulin sensitivity; thus, the treatment of myotubes with recombinant sFRP3 could significantly restore the inhibited insulin signalling induced by cytokine.138